These findings support that genomic evolution occurs at the earliest stages of breast cancer progression (within the ducts) in which driver events including TP53, PIK3CA mutations and HER2 amplifications are present at the DCIS stage, before breaking through the basement membrane of the ducts to establish the invasive disease. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.